About MAXCYTE, INC.
MaxCyte provides best-in-class electroporation systems, including the ExPERT DTx™, designed to accelerate discovery with high-viability performance and scalable delivery across a range of applications. The company focuses on cell engineering and gene editing technologies.
Electroporation systems for cell engineeringGene editing risk assessment servicesHigh-efficiency transfection across a wide range of applicationsScalable delivery for GMP-compliant manufacturingSupport for cell therapy, antibody & protein production, viral vector production, and vaccine development
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $12K | |
| 26-003578 MAXCYTE EXPERT GTX ELECTROPORATION DEVICE AND INSTALLATION/OPERATIONAL QUALIFICATION (IQ/OQ) | Department of Health and Human Services | $126K | |
| EXPERT ATX ELECTROPORATION PLATFORM, GENERATION 3 WITH ACCESSORIES (REGION SPECIFIC POWER CORD) | Department of Health and Human Services | $55K | |
| Federal contract award | Department of Health and Human Services | $375K | |
| Federal contract award | Department of Veterans Affairs | $34K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MAXCYTE, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.